RAUVAL Drug Patent Profile
✉ Email this page to a colleague
When do Rauval patents expire, and what generic alternatives are available?
Rauval is a drug marketed by Pal Pak and is included in one NDA.
The generic ingredient in RAUVAL is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RAUVAL?
- What are the global sales for RAUVAL?
- What is Average Wholesale Price for RAUVAL?
Summary for RAUVAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | RAUVAL at DailyMed |
US Patents and Regulatory Information for RAUVAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pal Pak | RAUVAL | rauwolfia serpentina root | TABLET;ORAL | 009108-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pal Pak | RAUVAL | rauwolfia serpentina root | TABLET;ORAL | 009108-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
